TY - JOUR
T1 - Portable, wearable and implantable artificial kidney systems
T2 - needs, opportunities and challenges
AU - Ramada, David Loureiro
AU - de Vries, Joost
AU - Vollenbroek, Jeroen
AU - Noor, Nazia
AU - ter Beek, Odyl
AU - Mihăilă, Silvia M.
AU - Wieringa, Fokko
AU - Masereeuw, Rosalinde
AU - Gerritsen, Karin
AU - Stamatialis, Dimitrios
N1 - Funding Information:
D.L. Ramada acknowledges the financial support of the Top Sector Life Sciences & Health (Health~Holland), NODIAL project 21OP + 035). D. Stamatialis, S.M. Mihaila, R. Masereeuw, K. Gerritsen and N. Noor acknowledge the financial support of the Strategic alliance of the University of Twente, University of Utrecht, and University Medical Center Utrecht. D. Stamatialis and R. Masereeuw acknowledge the financial support of the “European Uremic Toxin working group” (EUTox) of the “European Society for Artificial Organs” (ESAO) endorsed by the “European Renal Association-European Dialysis Transplantation Association” (ERA-EDTA). K. Gerritsen, J. de Vries, R. Masereeuw and F. Wieringa acknowledge the financial support of the European Commission (KIDNEW, HORIZON-EIC-2022 Pathfinder program, grant agreement no. 101099092). The authors thank J.A.W. Jong (Neokidney BV) for critically reviewing the manuscript and Dr. A. Verschueren (IMEC) for creating the initial concept for Fig. .
Publisher Copyright:
© 2023, Springer Nature Limited.
PY - 2023/8
Y1 - 2023/8
N2 - Haemodialysis is life sustaining but expensive, provides limited removal of uraemic solutes, is associated with poor patient quality of life and has a large carbon footprint. Innovative dialysis technologies such as portable, wearable and implantable artificial kidney systems are being developed with the aim of addressing these issues and improving patient care. An important challenge for these technologies is the need for continuous regeneration of a small volume of dialysate. Dialysate recycling systems based on sorbents have great potential for such regeneration. Novel dialysis membranes composed of polymeric or inorganic materials are being developed to improve the removal of a broad range of uraemic toxins, with low levels of membrane fouling compared with currently available synthetic membranes. To achieve more complete therapy and provide important biological functions, these novel membranes could be combined with bioartificial kidneys, which consist of artificial membranes combined with kidney cells. Implementation of these systems will require robust cell sourcing; cell culture facilities annexed to dialysis centres; large-scale, low-cost production; and quality control measures. These challenges are not trivial, and global initiatives involving all relevant stakeholders, including academics, industrialists, medical professionals and patients with kidney disease, are required to achieve important technological breakthroughs.
AB - Haemodialysis is life sustaining but expensive, provides limited removal of uraemic solutes, is associated with poor patient quality of life and has a large carbon footprint. Innovative dialysis technologies such as portable, wearable and implantable artificial kidney systems are being developed with the aim of addressing these issues and improving patient care. An important challenge for these technologies is the need for continuous regeneration of a small volume of dialysate. Dialysate recycling systems based on sorbents have great potential for such regeneration. Novel dialysis membranes composed of polymeric or inorganic materials are being developed to improve the removal of a broad range of uraemic toxins, with low levels of membrane fouling compared with currently available synthetic membranes. To achieve more complete therapy and provide important biological functions, these novel membranes could be combined with bioartificial kidneys, which consist of artificial membranes combined with kidney cells. Implementation of these systems will require robust cell sourcing; cell culture facilities annexed to dialysis centres; large-scale, low-cost production; and quality control measures. These challenges are not trivial, and global initiatives involving all relevant stakeholders, including academics, industrialists, medical professionals and patients with kidney disease, are required to achieve important technological breakthroughs.
UR - http://www.scopus.com/inward/record.url?scp=85160840946&partnerID=8YFLogxK
U2 - 10.1038/s41581-023-00726-9
DO - 10.1038/s41581-023-00726-9
M3 - Review article
C2 - 37277461
AN - SCOPUS:85160840946
SN - 1759-5061
VL - 19
SP - 481
EP - 490
JO - Nature Reviews Nephrology
JF - Nature Reviews Nephrology
IS - 8
ER -